Do deleterious mutations act synergistically? Metabolic control theory provides a partial answer

scientific article

Do deleterious mutations act synergistically? Metabolic control theory provides a partial answer is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID1205292
P698PubMed publication ID8417983

P2093author name stringSzathmáry E
P2860cites workEvolution of bacterial transformation: is sex with dead cells ever better than no sex at all?Q24532228
The control of fluxQ28237216
Metabolic flux and fitnessQ33952746
Mutation-selection balance and metabolic control theoryQ33958757
Deleterious mutations and the evolution of sexual reproductionQ34164458
The molecular basis of dominance.Q34283978
Metabolic growth rate control in Escherichia coli may be a consequence of subsaturation of the macromolecular biosynthetic apparatus with substrates and catalytic componentsQ36582943
Growth rate of Escherichia coliQ37295272
Molecular Democracy: Who Shares the Controls?Q39827592
Genetic transformationQ40313014
Dominance, pleiotropy and metabolic structure.Q42960206
A general model to account for enzyme variation in natural populations. V. The SAS--CFF modelQ45105163
Haploidy or diploidy: which is better?Q45672766
Localized sex in bacteriaQ59062612
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)127-132
P577publication date1993-01-01
P1433published inGeneticsQ3100575
P1476titleDo deleterious mutations act synergistically? Metabolic control theory provides a partial answer
P478volume133

Reverse relations

cites work (P2860)
Q28754894A framework for evolutionary systems biology
Q42151847A test for epistasis among induced mutations in Caenorhabditis elegans
Q38378680Adaptive dynamics of regulatory networks: size matters
Q35765287Dietary stress does not strengthen selection against single deleterious mutations in Drosophila melanogaster
Q34643339Drift increases the advantage of sex in RNA bacteriophage Phi6.
Q37412772Environment determines epistatic patterns for a ssDNA virus
Q33891661Estimating directional epistasis
Q42021004Evolution of dominance in metabolic pathways.
Q42128822Evolution of recombination due to random drift
Q30671403Fisher's geometric model of adaptation meets the functional synthesis: data on pairwise epistasis for fitness yields insights into the shape and size of phenotype space
Q34608241Fluxes and metabolic pools as model traits for quantitative genetics. I. The L-shaped distribution of gene effects.
Q55031183Heterosis Is a Systemic Property Emerging From Non-linear Genotype-Phenotype Relationships: Evidence From in Vitro Genetics and Computer Simulations.
Q35105723Mapping the fitness landscape of gene expression uncovers the cause of antagonism and sign epistasis between adaptive mutations.
Q33856660Mutation and the evolution of recombination
Q41065481On the mechanistic nature of epistasis in a canonical cis-regulatory element
Q45994253Parallel emergence of negative epistasis across experimental lineages.
Q41864870Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene
Q33723235Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks
Q90244482Recent insights into the genotype-phenotype relationship from massively parallel genetic assays
Q41889957Recessive mutations and the maintenance of sex in structured populations.
Q33964525Spontaneous mutation rate of modifiers of metabolism in Drosophila
Q43092006Synergistic fitness interactions and a high frequency of beneficial changes among mutations accumulated under relaxed selection in Saccharomyces cerevisiae
Q26860873The causes of epistasis
Q24533243The evolution of bacterial transformation: sex with poor relations
Q33688870The evolution of control and distribution of adaptive mutations in a metabolic pathway
Q34610474The evolution of recombination in a heterogeneous environment.
Q41972370The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase
Q37755968The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Search more.